BIOGEN INC. Other Cash Equivalents, at Carrying Value
BIOGEN INC. (BIIB) had Other Cash Equivalents, at Carrying Value of $589.60 million as of 2011-03-31, per its 10-Q filed 2011-04-21.
Discontinued › Notes › Cash Equivalents, at Carrying Value
us-gaap:OtherCashEquivalentsAtCarryingValue · last filed 2011-04-21
- 2011-03-31: Other Cash Equivalents, at Carrying Value $589.60M.
- 2010-12-31: Other Cash Equivalents, at Carrying Value $621.80M.
- 2010-09-30: Other Cash Equivalents, at Carrying Value $385.80M.
- 2010-06-30: Other Cash Equivalents, at Carrying Value $475.30M.
| Period end | Other Cash Equivalents, at Carrying Value |
|---|---|
| 2011-03-31 | $589.60M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $621.80M 10-Q · filed 2011-04-21 |
| 2010-09-30 | $385.80M 10-Q · filed 2010-10-26 |
| 2010-06-30 | $475.30M 10-Q · filed 2010-07-20 |
| 2009-12-31 | $399.50M 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |